§ Mr. HealdTo ask the Secretary of State for Health what estimate he has made of the number of patients not receiving atypical anti-psychotic drugs who could benefit from them. [17217]
§ Jacqui Smith[holding answer 22 November 2001]: This estimate has not been made. The National Institute for Clinical Excellence (NICE) has been asked to appraise the clinical and cost effectiveness of atypical antipsychotics in schizophrenia. This guidance is due to be published in March 2002.